4

OWNERSHIP DOCUMENT

Company: Eloxx Pharmaceuticals, Inc.
Filed: January 31, 2023
Period of Report: January 30, 2023
Accession Number: 0001104659-23-008597

View Document ↗ View on SEC.gov ↗